Pharmaceutical and life sciences

Strategic services and solutions to help organizations compete in an evolving health market and improve cost-efficiency and profitability

Pharmaceutical and life sciences companies are facing increasingly complex challenges globally and must have the scientific, commercial and operational capabilities to compete and deliver value for patients and investors. PwC’s sector team combines our industry knowledge, experience and technology to help create sustained outcomes for your business. We work with leaders across the value chain to help you innovate, thrive and grow, every step of the way.

How PwC can help solve complex challenges across the pharma and life sciences value chain

Our team of industry specialists is committed to helping your organization deliver positive outcomes for patients and investors. We can help you reinvent your business model by reshaping portfolios, innovating the patient experience, digitizing the value chain, resetting the cost base and transacting to transform.

We work closely with our clients to drive innovation and advance the development of products to bring to patients. We work with pharma leaders to help their organizations optimize performance while balancing quality and regulatory requirements. Our advisors have a wealth of industry-based R&D functional expertise and strategic consulting experience with a deep understanding of finance, tax, risk management, compliance, operations and human resources. With this breadth of capabilities, we are able to help our clients effectively evaluate, plan and execute their scientific, clinical, quality and regulatory objectives.

Learn more

In the current environment of poor product pipelines and broader customer bases, the traditional sales and marketing model of driving revenue with ever-larger sales forces is no longer sustainable. Pharmaceutical and medical device companies need to achieve both commercial and operational efficiency to secure their success. Let us help you effectively manage the new obstacles you’re facing today to ensure your organization remains stable and profitable.

Learn more

In today’s uncertain environment, organizations are facing new and unique supply chain challenges. Having active visibility of critical supply chain components, materials, interdependencies and data to properly assess potential operational and financial risk is more crucial than ever before. Companies need to plan and manage immediate contingencies and create a more resilient supply chain in the longer term. We work with our clients to identify options from integrated planning through distribution, to understand potential risks, and design and implement solutions to assure supply continuity, improve delivery performance and reduce costs.

Learn more

With unprecedented shifts in the landscape impacting patient care, biopharma’s dependence on medical affairs to sustain patient centricity has never been more important. Coupled with health care providers' growing reliance on medical affairs for the latest evidence, insights, knowledge and opportunities to conduct research in the real world, medical affairs transformation is moving forward at a fast pace.

Learn more

Pharma and life sciences are among the most heavily regulated industries in the world. The regulatory and tax environments are continuously changing in response to globalization, emerging markets, the increasing complexity of disease targets, the introduction of new technologies and the rising sophistication and demands of both patients and regulators. Keeping pace with changing regulation requires good processes and procedures that ensure adherence and enable effective global, national and local management. We work with our clients to audit and develop management systems that enable greater transparency across the firm, inform the development of new approaches to a broad range of regulatory and tax compliance, and help improve performance.

Learn more

Companies are addressing important questions about existing and future revenue generation, and how to align operational and financial tactics to enable their chosen corporate strategies. We are working with our clients to explore strategic options and begin the process today of restructuring their businesses for tomorrow. We help to identify those areas with the most realistic potential and devise and review pragmatic business plans that maximize value. Whatever the new venture, buying at the price, integrating the different elements and ensuring tax efficiencies throughout is key to ensuring maximum value.

Learn more



Contact us

Glenn Hunzinger

Glenn Hunzinger

US Pharma and Life Sciences Leader, PwC US

Laura  Robinette

Laura Robinette

Global Engagement Partner, Health Industries Trust Solutions Leader, PwC US

Follow us